Artal Participations S.a r.l 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-09 5:08 pm Sale | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Artal Participations S.a r.l | 0 0.000% | -15,066,043![]() (Position Closed) | Filing |
2023-02-10 7:21 pm Unchanged | 2022-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Artal Participations S.a r.l | 15,066,043 5.600% | 0 (Unchanged) | Filing |
2021-07-12 4:56 pm Purchase | 2021-06-22 | 13G | Ambrx Biopharma Inc. AMAM | Artal Participations S.a r.l | 15,066,043 5.700% | 15,066,043![]() (New Position) | Filing |